BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 24, 2018

Study Completion Date

November 30, 2020

Conditions
Type A Aortic Dissection
Interventions
DEVICE

BioGlue Surgical Adhesive

BioGlue (produced by CryoLife in Kennesaw, GA) is a surgical adhesive with two components respectively purified bovine serum albumin (BSA) and Glutaraldehyde (their proportions are 4:1). Crosslinked bonds (covalent bonds) of Glutaraldehyde cross-link the protein on the surface of the tissue and the amino residue of the bovine serum albumin. BioGlue also adheres to the synthetic matrix material by a mechanical interlocking mechanism in the space of graft matrix.

OTHER

Traditional Surgical Repair

Traditional surgical repair as determined by the surgeon

Trial Locations (7)

Unknown

Beijing Anzhen Hospital, Capital Medical University, Beijing

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing

Nanjing First Hospital, Nanjing

Changhai Hospital,The Second Military Medical University, Shanghai

Zhongshan Hospital, Fudan University, Shanghai

Wuhan Asia Heart Hospital, Wuhan

Henan Provincial People's Hospital, Zhengzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CryoLife, Inc.

INDUSTRY

NCT03369977 - BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients | Biotech Hunter | Biotech Hunter